Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)

Study Overview
=================
Brief Summary
-----------------
In this survey study, researchers want to find out more about how physicians are treating patients diagnosed with reduced kidney function (chronic kidney disease, CKD) and high blood sugar level (type 2 diabetes); what physicians know about the different treatment options available; and how they use this knowledge to treat their patients successfully. Additionally, researchers want to gather information about patient's awareness of their disease and which criteria they consider important for their treatment of the disease. The study will survey a total of 150 patients with type 2 diabetes: 50 patients with mild CKD; 50 patients with moderate CKD; and 50 patients with severe CKD. Patients eligible for this study can be male or female and should be at least 18 years old. In addition, a total of 150 physicians will be surveyed. Physicians eligible for this study may be general practitioners, endocrinologist, or nephrologists.

Detailed Description
-----------------
The primary objective in this study is to assess the awareness, values and preferences of patients and physicians with respect to the risks, consequences and management of chronic kidney disease (CKD) in patients with type 2 diabetes. Secondary objectives aim to assess awareness of available CKD treatments, referral tools and communication between patients and physicians. Both patients and physicians will complete a survey that consists of various questions regarding the knowledge of disease, values and treatments, patient-physician interaction, physician referral tools and disease risk management.

Official Title
-----------------
Awareness of Diagnosis and Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes

Conditions
-----------------
Renal Insufficiency, Chronic

Intervention / Treatment
-----------------
* Other: No intervention


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For patient cohort: Diagnosis of type 2 diabetes eGFR < 60 ml/min per 1.73 m2 (measured within the last year) OR eGFR ≥ 60 ml/min per 1.73 m2 and uACR ≥ 2 (measured within the last year) No documented non-diabetic etiology for renal disease For physician cohort: Licensed general practitioner, endocrinologist or nephrologist Currently providing care for patients with chronic kidney disease and type 2 diabetes Exclusion Criteria: Patients with chronic kidney disease and type 2 diabetes who are physicians Physicians with chronic kidney disease and type 2 diabetes

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| CKD-Patients<br>Cohort consisting of adult patients with a known diagnosis of type 2 diabetes and evidence of chronic kidney disease (CKD) | Other: No intervention<br>* No intervention, observational study<br>|
| Physicians treating CKD<br>Cohort consisting of licensed general practitioners, endocrinologists and nephrologists who are currently treating patients with both chronic kidney disease (CKD) and type 2 diabetes | Other: No intervention<br>* No intervention, observational study<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Awareness of chronic kidney disease in T2D | Awareness will be summarized descriptively based on various survey questions. | 1 day | 
| Values regarding chronic kidney disease in T2D | Values regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions. | 1 day | 
| Preferences regarding chronic kidney disease in T2D | Preferences regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions. | 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Awareness of available treatments for chronic kidney disease in T2D | Awareness of available treatments will be summarized descriptively based on various survey questions. | 1 day | 
| Physician awareness of available referral tools for the management of chronic kidney disease in T2D | Physician cohort only. Referral tools may comprise of various standard guidelines (e.g. KidneyWise, KDIGO guidelines, Diabetes Canada guidelines). A higher number of referral tools known by physicians indicates a better awareness of CKD referral tools. | 1 day | 
| Time point of communicated CKD diagnosis |  | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Chronic kidney disease (CKD), Type 2 Diabetes (T2D), Patient awareness, Physician awareness, Interaction patient physician